to right are:
1. Dr. K. R. Kohli, Dean R. A. Podar Medical
2. Mr. K. D. Shroff, MD of Charak Pharmaceuticals.
3. Mr. D.M. Parikh, MD of Zandu Pharmaceutical Works Ltd.
4. Mr. G. S. Gill IAS, Secretary to Govt. Of Maharashtra on Medical
Education And Drugs Dept.
5. Mr. Ravi Prasad, CEO & President of Himalaya Drug Company.
6. Mr. Ranjit Puranik, CEO of Shri Dhootpapeshwar Ltd. Mumbai.
meeting was called by the government of Maharashtra for the industry
and academic correlation for the common purpose of promoting Ayurveda
at national and international level. There was an excellent response
in the form of CEOs and Managing Directors of Himalaya Drug Company,
Zandu Pharmaceutical Works Ltd., Shri Dhootpapeshwar Ltd. Charak
Pharmaceuticals all participating actively in this meeting. This
meeting was chaired by the Secretary of Medical Education and Drugs
- Mr G.S.Gill in the campus of Podar Ayurvedic institutions at Worli,
Mumbai - 18.
Dr. K.R.Kohli, the Dean of Podar Ayurvedic
institutions, made the purpose of the meeting known in detail. The
Secretary to Government Mr G.S.Gill further made it known to the
members that Govt. of Maharashtra was serious on promoting Ayurveda.
He stressed that the time was mature for the industry now to actively
participate in globalising Ayurveda in the correct form. Mr Ravi
Prasad, President and CEO of Himalaya Drug Company insisted the
need of promoting Ayurveda as contemporary medicine and not as an
alternative system of medicine. He emphasized on the need of taking
up the regulatory issues related to licensing of drugs with the
European nations and U.S.Mr.D.M.Parikh, managing Director of Zandu
Pharmaceutical Works supported the views of Mr. Ravi Prasad.
Mr. Ranjit Puranik was vocal about immediate
formation of a society comprising of the Ayurvedic Pharmaceutical
industry and the experts of Ayurveda, which can disseminate knowledge
of Ayurveda in the language that people understand. He also expected
this kind of society to build bridges to impart knowledge of Ayurveda
to doctors of other systems of medicine. Mr K.D.Shroff, MD of Charak
pharmaceutical was also of the same opinion. Mr. Sunil Duggal, CEO
of Dabur India Ltd. Extended whole hearted support for industry
academia partnership in this proposed society through his letter
as he could not attend the meeting.
It was decided that this society would function
for promoting contemporary Ayurveda Research and Education. Secretary
Govt. of Maharashtra would be the Chairman and the MD/ CEO of one
of the Ayurvedic Pharmaceutical companies will be the co - chairman.
Dr Kohli, the Dean of Podar Ayurvedic institution shall function
as the General Secretary of the Society. Membership shall also be
offered to the travel agents of repute as their help was thought
to be mandatory in the globalisation of Ayurveda and in promoting
Ayurvedic medical tourism. A point was also made that procedures
like Panchkarma which have become popular worldwide should be taken
up by the Pharmaceutical industry for improvisation.
Mr. Gill offered allotment of space in the
campus Podar institutions for the functioning of the society. Membership
of the society will be open to all Ayurvedic pharmaceuticals and
eminent Ayurveda physicians.
The meeting ended with a note that Ayurvedic pharmaceutical industry
whole-heartedly supports such relation with the industry and academia.